P46 | CIRCULATING PLASMA CELLS AS A DYNAMIC BIOMARKER IN MULTIPLE MYELOMA PATIENTS RECEIVING CAR-T AND BISPECIFIC ANTIBODY THERAPY

Chimeric antigen receptor T-cell (CAR-T) therapy and bispecific antibodies (bsAbs) have profoundly reshaped the treatment landscape of relapsed/refractory multiple myeloma (RRMM). Despite their efficacy, standardized tools for early response assessment and peripheral residual disease (PRD) monitori...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	I. Vigliotta, A. Varacalli, M. Talarico, M. Puppi, S. Armuzzi, B. Taurisano, I. Pistis, V. Solli, V. M. Vuong, E. Borsi, A. Vitale, G. Mazzocchetti, A. Croce, M. Martello, A. Poletti, M. Cavo, E. Manzato, E. Zamagni, C. Terragna
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Ferrata Storti Foundation 2026-04-01
Schriftenreihe:	Haematologica
Online-Zugang:	https://haematologica.org/article/view/14092
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!